Adjuvant Global Health Technology Fund, L.P., 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 479,081 shares at $15.00 ($2.5M) on 2022-03-29, disclosed to the SEC on 2022-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 312,415 | $0 | 0.0% |
| 2 | $15.00 | 166,666 | $2.5M | 100.0% |
| Total | $5.22 avg | 479,081 | $2.5M | 100% |
| Filing → |